Rubella virus infection in endothelial cells reduces angiogenesis via interferon beta-induced CXCL10
Rubella virus (RuV) infection during pregnancy can lead to abortion, stillbirth, and embryonic defects, resulting in congenital rubella syndrome (CRS). It is estimated that there are still 100,000 cases of CRS per year in developing regions with a mortality rate of over 30%. The molecular pathomecha...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
22 March 2023
|
| In: |
iScience
Year: 2023, Volume: 26, Issue: 4, Pages: 1-19 |
| ISSN: | 2589-0042 |
| DOI: | 10.1016/j.isci.2023.106352 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.isci.2023.106352 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S2589004223004297 |
| Author Notes: | Vivien Henschke, Konstanze Hild, Erik Schilling, Jan Haas, Vanina Filipova, Stephan Erbe, Roman König, Judith M. Hübschen, Ulrich Laufs, Claudia Claus, and Jes-Niels Boeckel |
| Summary: | Rubella virus (RuV) infection during pregnancy can lead to abortion, stillbirth, and embryonic defects, resulting in congenital rubella syndrome (CRS). It is estimated that there are still 100,000 cases of CRS per year in developing regions with a mortality rate of over 30%. The molecular pathomechanisms remain largely unexplored. Placental endothelial cells (EC) are frequently infected with RuV. RuV reduced the angiogenic and migratory capacity of primary human EC, as confirmed by treatment of EC with serum from RuV IgM-positive patients. Next generation sequencing analysis revealed the induction of antiviral interferon (IFN) type I and III and CXCL10. The RuV-induced transcriptional profile resembled the effects of IFN-β treatment. The RuV-mediated inhibition of angiogenesis was reversed by treatment with blocking and neutralizing antibodies targeting CXCL10 and the IFN-β receptor. The data identify an important role for antiviral IFN-mediated induction of CXCL10 in the control of EC function during RuV infection. |
|---|---|
| Item Description: | Online verfügbar 7. März 2023, Artikelversion 22. März 2023 Gesehen am 04.07.2023 |
| Physical Description: | Online Resource |
| ISSN: | 2589-0042 |
| DOI: | 10.1016/j.isci.2023.106352 |